UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 10-Q

(Mark One)

QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2022March 31, 2023

TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

For the transition period from __________ to ___________

Commission file number: 000-56453

LIMITLESS X HOLDINGS INC.

(Exact name of registrant as specified in its charter)

Delaware81-1034163
(State of Incorporation)(IRS Employer ID Number)

9454 Wilshire Blvd., #300, Beverly Hills, CA90212

(Address of Principal Executive Offices)

(855)413-7030

(Registrant’s Telephone number)

7400 E. Crestline Circle, Suite 130, Greenwood Village, CO 80111

(720) 273-0433

(Former Address and Telephone Number phone of principal executive offices)

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
N/AN/AN/A

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to the filing requirements for the past 90 days.

YesNo

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 for Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

YesNo

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filerAccelerated filer
Non-accelerated filerSmaller reporting company
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

YesNo

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

As of November 4, 2022,May 15, 2023, there were 117,893,4603,977,497 shares of the registrant’s common stock, $0.0001 par value, issued and outstanding, not including shares reserved for conversion of notes.outstanding.

 

 

TABLE OF CONTENTS

Page
PART 1 – FINANCIAL INFORMATION
Item 1.Financial Statements13
Unaudited Condensed Consolidated Balance Sheets13
Unaudited Condensed Consolidated Statements of Operations24
Unaudited Condensed Consolidated Statement of Changes in Stockholders’ EquityDeficit35
Unaudited Condensed Consolidated Statements of Cash Flows46
Notes to the Unaudited Condensed Consolidated Financial Statements57
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations1823
Item 3.Quantitative and Qualitative Disclosures About Market Risk1926
Item 4.Controls and Procedures1926
PART II - OTHER INFORMATION
Item 1.Legal Proceedings2027
Item 1A.Risk Factors2027
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds2027
Item 3.Defaults Upon Senior Securities2027
Item 4.Mine Safety Disclosures2027
Item 5.Other Information2027
Item 6.Exhibits2027
Signatures2128

i

2

 

LIMITLESS X HOLDINGS INC.

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements

LIMITLESS X HOLDINGS INC.

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

  September 30,
2022
  December 31,
2021
 
       
ASSETS      
       
Current Assets:      
Cash $919,978  $78,856 
Accounts receivables, net of allowance for doubtful accounts of $0 and $0, respectively  581,319   322,499 
Holdback receivables  2,342,496   162,226 
Prepaid  1,167   - 
Inventories, net  1,702,333   1,875,146 
Total current assets  5,547,293   2,438,727 
         
Non-Current Assets:        
Operating lease right-of-use asset, net  124,696   224,202 
Equipment, net  33,292   - 
Other assets  85,629   10,985 
Total non-current assets  243,617   235,187 
         
Total assets $5,790,910  $2,673,914 
         
LIABILITIES AND STOCKHOLDERS’ EQUITY        
         
Current Liabilities:        
Accounts payable and accrued expenses $2,246,920  $215,176 
Current portion of operating lease liabilities  126,297   132,200 
Royalty payable  704,203   - 
Refunds payable  373,149   207,599 
Chargebacks payable  254,319   100,350 
Income tax payable  22,906   22,906 
Note payable  35,000   - 
Convertible note payables  1,550,000   - 
Current portion of loan payables to shareholder  3,722,028   28,802 
Note payables to related parties  317,610   - 
         
Total current liabilities  9,352,432   707,033 
Loan payables to shareholder, less current portion  -   21,198 
Operating lease liabilities, less current portion  -   92,195 
Total liabilities  9,352,432   820,426 
         
Commitments and contingencies        
         
Stockholders’ Equity        
Preferred Stock - $0.0001 par value; 5,000,000 authorized shares; 500,000 shares issued and outstanding and 500,000 shares issued and outstanding at September 30, 2022 and December 31, 2021  50   50 
Common Stock- $0.0001 par value; 200,000,000 authorized  shares; 117,893,460 shares issued and outstanding and 104,893,504 shares issued and outstanding and 11,910,000 shares issuable at September 30, 2022 and December 31, 2021, respectively  11,789   11,680 
Additional paid-in-capital  4,954,767   1,837,094 
Retained earnings  (8,528,128)  4,664 
Total stockholders’ equity  (3,561,522)  1,853,488 
         
Total liabilities and stockholders’ equity $5,790,910  $2,673,914 
  March 31, 2023  December 31, 2022 
  (unaudited)  (audited) 
ASSETS        
         
Current Assets:        
Cash $147,805  $5,843,323 
Accounts receivables, net of allowance for doubtful accounts of
$232,374 and $0, respectively
  1,787,837   895,713 
Holdback receivables, net of allowance for doubtful accounts of
$0 and $1,300,855, respectively
  1,638,376   1,043,991 
Inventories, net  3,500,440   3,855,946 
Total current assets  7,074,458   11,638,973 
         
Non-Current Assets:        
Operating lease right-of-use asset, net  57,110   91,032 
Equipment, net  32,759   32,256 
Other assets  106,225   78,965 
Total non-current assets  196,094   202,253 
         
Total assets $7,270,552  $11,841,226 
         
LIABILITIES AND STOCKHOLDERS’ DEFICIT        
         
Current Liabilities:        
Accounts payable and accrued expenses $4,153,600  $2,419,051 
Current portion of operating lease liabilities  57,838   92,195 
Royalty payable  1,399,031   1,114,403 
Refunds payable  1,433,401   213,930 
Chargebacks payable  635,408   118,288 
Income tax payable  17,056   17,056 
Note payable  35,000   35,000 
Convertible note payables  9,675,000   9,175,000 
Current portion of loan payables to shareholder  4,462,028   4,462,028 
Note payables to related parties  1,247,011   1,247,011 
         
Total current liabilities  23,115,373   18,893,962 
Total liabilities  23,115,373   18,893,962 
         
Commitments and contingencies  -   - 
         
Stockholders’ Deficit        
Preferred Stock - $0.0001 par value; 30,000,000 authorized shares;
500,000 shares issued and outstanding and at March 31, 2023
and December 31, 2022
  50   50 
Common Stock- $0.0001 par value; 300,000,000 authorized shares;
3,929,834 shares issued at March 31, 2023 and December 31, 2022
  394   394 
Additional paid-in-capital  2,966,162   2,966,162 
Retained earnings  (18,811,427)  (10,019,342)
Total stockholders’ deficit  (15,844,821)  (7,052,736)
         
Total liabilities and stockholders’ deficit $7,270,552  $11,841,226 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.


3

 

LIMITLESS X HOLDINGS INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

  For the
three months
  For the
nine months
 
  ended
September 30,
2022
  ended
September 30,
2022
 
       
Sales      
Net sales $21,493,178  $39,726,435 
Rentals  2,500   7,500 
Total net sales  21,495,678   39,733,935 
         
Cost of sales        
Cost of sales  3,037,997   5,837,994 
Cost of sales - other  -   358 
Total cost of sales  3,037,997   5,838,352 
         
Gross profit  18,457,681   33,895,583 
         
Operating expenses:        
General and administrative  653,894   1,060,677 
Advertising and marketing  17,163,099   34,376,380 
Stock compensation for services  -   1,117,782 
Transaction fees  1,401,892   1,988,718 
Merchant fees  917,427   1,656,920 
Royalty fees  472,082   704,203 
Professional fees  272,963   940,945 
Payroll and payroll taxes  258,934   392,605 
Rent  41,177   121,570 
General and administrative expenses - other  5,138   23,783 
Consulting fees, related party  6,000   38,500 
Depreciation  1,036   4,649 
Total operating expenses  21,193,642   42,426,732 
         
Loss from operations  (2,735,961)  (8,531,149)
         
Other income (expense)        
Interest expense  (68,286)  (81,394)
Other income  -   57,756 
Gain on disposal of assets  -   28,397 
Total other income (expense), net  (68,286)  4,759 
         
Loss before income taxes  (2,804,247)  (8,526,390)
         
Income tax provision  -   6,402 
         
Net loss $(2,804,247) $(8,532,792)
         
Net loss per common share - basic and diluted $(0.02) $(0.14)
         
Weighted average number of common shares  113,686,938   59,582,185 
       
  For the three months March 31, 
  2023  2022 
       
Revenue        
Product sales $6,563,037  $7,075,362 
Service revenue  291,764   - 
Rentals  15,000   - 
Total revenue  6,869,801   7,075,362 
         
Cost of sales        
Cost of sales  1,229,894   882,549 
Total cost of sales  1,229,894   882,549 
         
Gross profit  5,639,907   6,192,813 
         
Operating expenses:        
General and administrative  586,206   31,534 
Advertising and marketing  10,055,504   5,243,678 
Transaction fees  411,268   14,481 
Merchant fees  713,194   354,683 
Royalty fees  284,628   - 
Professional fees  539,157   44,500 
Payroll and payroll taxes  1,335,927   70,422 
Rent  41,059   43,257 
Bad debt expense  232,374   - 
Consulting fees, related party  7,000   - 
Total operating expenses  14,206,317   5,802,555 
         
Income (loss) from operations  (8,566,410)  390,258 
         
Other income (expense)        
Interest expense  (225,627)  - 
Total other income (expense), net  (225,627)  - 
         
Income (loss) before income taxes  (8,792,037)  390,258 
         
Income tax provision  48   81,954 
         
Net income (loss) $(8,792,085) $308,304 
         
Net income (loss) per common share - basic and diluted $(2.24) $0.19 
         
Weighted average number of common shares  3,929,834   1,621,112 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.


4

 

LIMITLESS X HOLDINGS INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITYDEFICIT

              Common Stock  Additional     Total 
  Preferred Stock  Common Stock  Issuable  Pain-In  Retained  Stockholder’s 
  Shares  Amount  Shares  Amount  Shares  Amount  Capital  Earnings  Equity 
                            
Balance at December 31, 2021  500,000  $50   104,893,504  $10,489   11,910,000  $1,191  $1,837,094  $4,664  $1,853,488 
                                     
Issuance of common stock  -   -   2,910,000   291   (2,910,000)  (291)  2,000,000   -   2,000,000 
                                     
Issuance of common stock issuable  -   -   9,000,000   900   (9,000,000)  (900)  -   -   - 
                                     
Issuance of common stock for services  -   -   1,089,956   109   -   -   1,117,673   -   1,117,782 
                                     
Net loss  -   -   -   -   -   -   -   (8,532,792)  (8,532,792)
                                     
Balance at September 30, 2022 (unaudited)  500,000  $50   117,893,460  $11,789   -  $-  $4,954,767  $(8,528,128) $(3,561,522)
  Shares  Amount  Shares  Amount  Capital  Earnings  Deficit 
  Preferred Stock  Common Stock  

Additional

Paid-In

  Retained  

Total

Stockholder’s

 
  Shares  Amount  Shares  Amount  Capital  Earnings  Deficit 
                      
Balance at December 31, 2022  500,000  $     50   3,929,834  $394- $2,966,162  $(10,019,342) $(7,052,736)
                             
Net loss  -   -   -   --  -   (8,792,085)  (8,792,085)
                             
Balance at March 31, 2023 (unaudited)  500,000  $50   3,929,834  $394- $2,966,162  $(18,811,427) $(15,844,821)

              Common Stock  Additional    Total
  Preferred Stock  Common Stock  Issuable  Pain-In  Retained  Stockholder’s 
  Shares  Amount  Shares  Amount  Shares  Amount  Capital  Earnings  Equity 
                            
Balance at June 30, 2022 (unaudited)  500,000  $50   108,893,460  $10,889   9,000,000  $900  $4,954,767  $(5,723,881) $(757,275)
                                     
Issuance of common stock issuable  -   -   9,000,000   900   (9,000,000)  (900)  -   -   - 
                                     
Net loss  -   -   -   -   -   -   -   (2,804,247)  (2,804,247)
                                     
Balance at September 30, 2022 (unaudited)  500,000  $50   117,893,460   11,789   -   -  $4,954,767  $(8,528,128) $(3,561,522)
  Shares  Amount  Shares  Amount  Shares  Amount  Capital  Earnings  Deficit 
  Preferred Stock  Common Stock  

Common Stock

Issuable

  

Additional

Paid-In

  Retained  

Total

Stockholder’s

 
  Shares  Amount  Shares  Amount  Shares  Amount  Capital  Earnings  Deficit 
                            
Balance at December 31, 2021  500,000  $    50   3,496,150  $350   397,000  $40  $1,848,384  $4,664  $1,853,488 
                                     
Issuance of common stock  -   -   97,000   10   (97,000)  (10)  -   -   - 
                                     
Issuance of common stock issuable  -   -   300,000   30   (300,000)  (30)  -   -   - 
                                     
Net income  -   -   -   -   -   -   -   308,304   308,304 
                                     
Balance at March 31, 2022 (unaudited)  500,000  $50   3,893,150  $390   -  $-  $1,848,384  $312,968  $2,161,792 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.


5

 

LIMITLESS X HOLDINGS INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

  For the
nine months
 
  ended
September 30,
2022
 
    
Cash flows from operating activities:   
Net loss $(8,532,792)
     
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation  3,613 
Common stock issued for professional fees  1,117,782 
Changes in assets and liabilities:    
Accounts receivables, net  (258,820)
Holdback receivables  (2,180,270)
Inventories, net  172,813 
Other assets  (75,811)
Accounts payable and accrued expenses  1,967,850 
Refunds payable  165,550 
Royalty payable  704,203 
Chargebacks payable  153,969 
Net cash used in operating activities  (6,761,913)
     
Cash flows from investing activities:    
Proceeds from disposition of asset  28,397 
Net cash provided by financing activities  28,397 
     
Cash flows from financing activities:    
Proceeds from borrowings from related parties  317,610 
Proceeds from borrowings from shareholder  3,672,028 
Proceeds from borrowing  1,585,000 
Proceeds from issuance of common stock  2,000,000 
Net cash provided by financing activities  7,574,638 
     
Net increase in cash  841,122 
     
Cash – beginning of period  78,856 
     
Cash – end of period $919,978 
     
Supplemental disclosures of cash flow information    
Cash paid during the periods for:    
Interest $1,125 
Income taxes  - 
       
  For the three months ended March 31, 
  2023  2022 
       
Cash flows from operating activities:        
Net income (loss) $(8,792,085) $308,304 
         
Adjustments to reconcile net income (loss) to net cash provided by operating activities:        
Depreciation  1,101   - 
Changes in assets and liabilities:        
Accounts receivables, net  (892,124)  (1,267,350)
Holdback receivables  (594,385)  (549,347)
Inventories, net  355,506   127,240 
Other assets  (27,260)  - 
Accounts payable and accrued expenses  1,734,114   859,422 
Refunds payable  1,219,471   581,135 
Royalty payable  284,628   - 
Chargebacks payable  517,120   (24,535)
Income tax payable  -   81,954 
Net cash provided by (used in) operating activities  (6,193,914)  116,823 
         
Cash flows from investing activities:        
Purchases of equipment  (1,604)  - 
Net cash used in financing activities  (1,604)  - 
         
Cash flows from financing activities:        
Proceeds from borrowing  500,000   - 
Proceeds from borrowings from shareholder  -   150,000 
Net cash provided by financing activities  500,000   150,000 
         
Net increase (decrease) in cash  (5,695,518)  266,823 
         
Cash – beginning of period  5,843,323   78,856 
         
Cash – end of period $147,805  $345,679 
         
Supplemental disclosures of cash flow information        
Cash paid during the periods for:        
Interest $1,167  $- 
Income taxes $-  $- 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.


6

 

LIMITLESS X HOLDINGS INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note 1 – Organization and History

Vyta Corp (the “Vvta”) was incorporated in Nevada in June 1996. On August 20, 2010, Vvta changed its state of incorporation to Delaware and on November 5, 2010 changed its name toMay 11, 2022, Bio Lab Naturals, Inc., a Delaware corporation (“Bio Lab”).

Effective December 31, 2019, Bio Lab entered into a Reorganization Agreement with Prime Time Live, Inc. (“PTL”), a Colorado corporation, whereby PTL merged with a newly formed wholly owned subsidiary of Bio Lab, with the subsidiary being the survivor, in exchange for the Bio Lab issuing one share of its common stock for each share of PTL’s 5,500,000 issued and outstanding shares of common stock. As a result, PTL became a wholly owned subsidiary of Bio Lab.

As previously reported on a Current Report on Form 8-K filed with the Securities and Exchange Commission on May 13, 2022, Bio Lab entered into a Share Exchange Agreement (the “Agreement”“Share Exchange Agreement”) with Limitless X, Inc., a Nevada corporation (“LimitlessX”), and its 11 shareholders (the “LimitlessX Acquisition”) on May 11, 2022 (the “Merger”). The parties completed and closed the LimitlessX Acquisition on May 20, 2022 by issuing an aggregate of 97,000,0003,233,334 shares of common stock of Bio Lab to the LimitlessX shareholders (the “Closing”“Acquisition Closing”). According to the terms of the Share Exchange Agreement, Bio Lab is obligated to issuethen issued an additional 9,000,000300,000 shares of common stock to the LimitlessX shareholders pro rata to their interests in approximately six months from the Acquisition Closing as part of the LimitlessLimitlessX Acquisition. Concurrently with the LimitlessX Acquisition, Jaspreet Mathur, the founder and principal shareholder of LimitlessX, also purchased from Helion Holdings LLC, 500,000 shares of Bio Lab’s Class A Preferred Convertible Stock, which at all times have a number of votes equal to 60%60% of all of the issued and outstanding shares of common stock of Bio Lab.

On June 10, 2022, Bio Lab changed its name to Limitless X Holdings Inc. (“Limitless”).

The MergerLimitlessX Acquisition was accounted for as a “reverse merger” following the completion of the transaction. For accounting purposes, LimitlessX was deemed to be the accounting acquirer in the transaction and, consequently, the transaction was treated as a recapitalization of Bio Lab. Accordingly, LimitlessX’s assets, liabilities, and results of operations became the historical financial statements of the registrant. No step-up in basis or intangible assets or goodwill was recorded in this transaction.

LimitlessThe Company (as defined below) is a lifestyle brand, focused in the health and wellness industry. LimitlessThe Company provides nutritional supplements, wellness studies, and interactive training videos.videos, and marketing products. The Company’s mission of Limitless is to provide businesses within its industry a turnkey solution to sell products both online and in retail stores. LimitlessThe Company also provides its own products and wellness videos suitable for a wide range of ages and fitness. LimitlessCompany teams includesinclude sales, marketing, user interface design (UI), user experience design (UX), fulfillment, customer support, labeling, product manufacturing, consulting, retailing, and payment processing, among others.

The Company currently offers products online only, but anticipates expanding to brick-and-motor retail  stores and the wholesale marketplace in the future. The Company has manufacturing and distribution licensing agreements to market, manufacture, sell, and distribute branded products on behalf of its clients. The Company orders products from third party partner manufacturers that make the products according to the Company’s custom formulations, and brands them using the Company’s licensed trademarks. Products are then marketed and sold direct to consumers online. Orders are fulfilled and shipped directly from the Company’s licensors. The Company plans to offer global marketing services across all areas of the sales process, including market research, brand and product development, and digital advertising operating as an integrated marketing agency.

The Company operates in the following product and service sectors: (i) health products and (ii) digital marketing services. The health products sector includes the sales of health products in three primary vertical markets: (1) health & wellness; (2) beauty & skincare; and (3) the vapor industry. The digital marketing service sector includes digital marketing; digital and print design; social media marketing; and direct-to-consumer marketing.

Note 2 – Summary of Significant Accounting Policies

Principles of Consolidation and Reporting

The accompanying consolidated financial statements include the accounts of Limitless X Holdings Inc. (a holding company) and its wholly owned operating subsidiaries,subsidiaries: Limitless X, Inc.,; Vybe Lab Inc.; and Prime Time Live, Inc. (collectively, the “Company”). All intercompany balances have been eliminated during consolidation.

7

 

Use of Estimates in the Preparation of Consolidated Condensed Financial Statements

The preparation of consolidated condensed financial statements in conformity with generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Estimates also affect the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.


Cash and Cash Equivalents

The Company considers all liquid investments purchased with an initial maturity of three months or less to be cash equivalents. Cash and cash equivalents include demand deposits carried at cost which approximates fair value. The Company maintains its cash in institutions insured by the Federal Deposit Insurance Corporation (“FDIC”).

Concentration of Credit Risk

The Company offers its services to a small number of clients. ThisThe risk of non-payment by these clients is considered minimal and the Company does not generally obtain collateral for sales. The Company continually monitors the credit standing of its clients.

Accounts Receivable, net

Accounts receivable, net consists primarily of trade receivables, net of allowances for doubtful accounts. The Company sells its products for cash or on credit terms, which are established in accordance with local and industry practices and typically require payment within 30 days of delivery. The Company estimates its allowance for doubtful accounts and the related expected credit loss based upon the Company’s historical credit loss experience, adjusted for asset-specific risk characteristics, current economic conditions, and reasonable forecasts. Accounts receivables are written off when determined to be uncollectible. TheFor the three months ended March 31, 2023, the Company did not require and did not haverequired an allowance for doubtful accounts.accounts of $232,374.

Holdback Receivables

The Company uses a third-party payment processor forprimarily sells its customers. When such customers make a purchase,products online using various third party sales affiliates. These affiliates (online marketing campaign companies) are paid certain commission based on their ability to provide the Company’s products through online sales. All payments are delivered directlyprocessed through various gateways and are settled through the Company’s payment gateway settler. The Company payment gateway settler is not responsible for settlements that are not paid due to processing bank failure. The Company holds responsibility for all the third-partyrisk in all transactions and processing systems. The payment processor andgateway settler charges a reserve fee to mitigate the net amount is distributed torisk on their end for any loss of funds or damages.

Distributions of the Company.

Distributionsholdback receivables from the third-party payment processorgateway settler are based on several criteria, such as return and chargeback history, associated risk for the specific business vertical, average transaction amount, and so on. In order to mitigate processing risks, there are policies regarding reserve requirements and payment in arrears in place.

The total holdback receivables balance reflects the 10%0 to 10% reserve on gross sales and additional reserves by the third-party processor for additional returns and chargebacks.chargebacks if needed. Based on aging of the holdback receivables, the Company has determined that an allowance for doubtful accounts of $1,300,855 or 55% of holdback receivables should be deemed uncollectible recorded as bad debt expense. Thus, the adjusted holdback receivables balance was $1,043,991 as of December 31, 2022. As of March 31, 2023, the holdback receivables balance was $1,638,376.

8

 

Inventories, net

Inventories are valued at the lower of cost or net realizable value on a first-in, first-out basis, adjusted for the value of inventory that is determined to be excess, obsolete, expired, or unsaleable. Inventories primarily consisted of finished goods.

Advertising and Marketing

Advertising and marketing costs are charged to expense as incurred. Advertising and marketing costs were approximately $17,163,099$10,055,504 and $34,376,380$5,243,678 for the three and nine months ended September 30,March 31, 2023 and 2022, respectively, and are included in operating expenses in the accompanying statement of income.


Equipment

Equipment is recorded at cost and consists of screen video and related equipment. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When equipment is retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Depreciation of equipment is over the estimated useful life of five to ten years using the straight-line method for consolidated financial statement purposes.

Schedule of Equipment

 September 30, December 31,       
 2022  2021  March 31, 2023  December 31, 2022 
          
Machinery and equipment $37,463  $       -  $39,067  $37,463 
Total  37,463   -   39,067   37,463 
                
Less: accumulated depreciation  (4,171)  -   (6,308)  (5,207)
                
Total equipment, net $33,292  $-  $32,759  $32,256 

Depreciation expense for the three and nine months ended September 30,March 31, 2023 and 2022 was $1,036$1,101 and $4,649,$0, respectively.

During the nine months ended September 30, 2022, the Company reported a gain of $28,397 on the disposal of assets.

Revenue Recognition

Product Sales

The Company recognizes revenue when performance obligations under the terms of a contract with its customer are satisfied. The Company has determined that fulfilling and delivering products is a single performance obligation. Revenue is recognized at the point in time when the Company has satisfied its performance obligation and the customer has obtained control of the products.products or when the service is fully .. This generally occurs when the product is delivered to or picked up by the customer based on applicable shipping terms, which is typically within 15 days. Revenue is measured as the amount of consideration expected to be received in exchange for fulfilled product orders,

While customers generally have a right to return defective or non-conforming products, past experience has demonstrated that product returns have been immaterial. Customer remedies for defective or non-conforming products may include a refund or exchange. As a result, the right of return is estimated and recorded as a reduction in revenue at the time of sale, if necessary.

The Company’s customer contracts identify product quantity, price, and payment terms. Payment terms are granted consistent with industry standards. Although some payment terms may be more extended, the majority of the Company’s payment terms are less than 30 days. As a result, revenue is not adjusted for the effects of a significant financing component. Amounts billed and due from customers are classified as Accounts Receivables on the Balance Sheet.

9

 

The Company utilizes third-party contract manufacturers for the manufacture of its products. The Company has evaluated whether it is the principal or agent in these relationships. The Company has determined that it is the principal in all cases as it retains the responsibility for fulfillment and risk of loss, as well as for establishing the price.

In accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers, the Company has elected the practical expedient to expense the incremental costs to obtain a contract, because the amortization period would be less than one year, and the practical expedient for shipping and handling costs. Shipping and handling costs incurred to deliver products to customers are accounted for as fulfillment activities, rather than a promised service, and as such are included in Cost of Goods Sold in the Statements of Operations.

Service Revenue

Service revenue consists of digital marketing revenue.

Revenue related to digital marketing is recognized over time as services are provided to the customer. The Company sells digital marketing, digital and print design, social media marketing, and direct-to-consumer marketing and thus uses standalone selling prices as the basis for revenue. Payment for digital marketing services is typically received at the point when control transfers to the customer or in accordance with payment terms customary to the business. There was no deferred revenue related to services revenue as of March 31, 2023 and December 31, 2022.

Cost of Goods SoldSales

Cost of goods soldsales includes the cost of inventory sold during the period, net of allowances, as well as, commission fees, returns, chargebacks, distribution, and, shipping and handling costs. The amount shown is net of various rebates from third-party vendors in the form of payments.


Refunds Payable

If customers are not satisfied for any reason, they may request a full refund, processed to the original form of payment, within 30 days from the order date. If the order has already been shipped, the Company charges a 20%20% restocking fee. The Company’s estimate of the reserve is based upon the Company’s most historical experience of actual customer returns. Additionally, the Company considers other factors in estimating the reserve, such as hiring a new internal team with more resources for the refund process. For the three months ended March 31, 2023, the average rate of return is 29%. For the three months ended March 31, 2023, the Company determined the refund reserve to be $1,433,401 by using the last two weeks of sales of the period of $4,872,861 with the average rate of return of 29% for the three months ended March 31, 2023.

As of September 30, 2022March 31, 2023 and December 31, 2021,2022, refunds payable were $373,149$1,433,401 and $207,599,$213,930, respectively.

Chargebacks Payable

Once customers successfully dispute chargebacks with the payment processor, the Company returns such funds to the payment processor to return to the customer. For the three months ended March 31, 2023, the average rate of return was 13%. For the three months ended March 31, 2023, the Company determined the chargeback reserve to be $635,408 by using the last two weeks of sales of the period of $4,872,861 with the average rate of chargebacks of 13% for the three months ended March 31, 2023.

As of September 30, 2022March 31, 2023 and December 31, 2021,2022, chargebacks payable were $254,319$635,408 and $100,350,$118,288, respectively.

Other Comprehensive Loss

The Company has no material components of other comprehensive loss and accordingly, net loss is equal to comprehensive loss for the period.

10

 

Debt

Convertible debt – derivative treatment – When the Company issues debt with a conversion feature, it must first assess whether the conversion feature meets the requirements to be treated as a derivative, as follows: a) one or more underlying terms, typically the price of the Company’s common stock; b) one or more notional amounts or payment provisions or both, generally the number of shares upon conversion; c) no initial net investment, which typically excludes the amount borrowed; and d) net settlement provisions, which in the case of convertible debt generally means the stock received upon conversion can be readily sold for cash. An embedded equity-linked component that meets the definition of a derivative does not have to be separated from the host instrument if the component qualifies for the scope exception for certain contracts involving an issuer’s own equity. The scope exception applies if the contract is both a) indexed to its own stock; and b) classified in shareholders’ equity in its statement of financial position.

If the conversion feature within convertible debt meets the requirements to be treated as a derivative, the Company estimates the fair value of the convertible debt derivative using the Black Scholes method upon the date of issuance. If the fair value of the convertible debt derivative is higher than the face value of the convertible debt, the excess is immediately recognized as interest expense. Otherwise, the fair value of the convertible debt derivative is recorded as a liability with an offsetting amount recorded as a debt discount, which offsets the carrying amount of the debt. The convertible debt derivative is revalued at the end of each reporting period and any change in fair value is recorded as a gain or loss in the Consolidated Statement of Operations. The debt discount is amortized through interest expense over the life of the debt.

If the conversion feature does not qualify for either the derivative treatment, the convertible debt is treated as traditional debt.

Income Taxes

The accounting standard on accounting for uncertainty in income taxes addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under that guidance, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by taxing authorities based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement.

Goodwill

In accordance with GAAP, goodwill cannot be amortized, however, it must be tested annually for impairment. This impairment test is calculated at the reporting unit level. The goodwill impairment test has two steps. The first identifies potential impairments by comparing the fair value of a reporting unit with its book value, including goodwill. If the fair value of the reporting unit exceeds the carrying amount, goodwill is not impaired and the second step is not necessary. If the carrying value exceeds the fair value, the second step calculates the possible impairment loss by comparing the implied fair value of goodwill with the carrying amount. If the implied goodwill is less than the carrying amount, a write-down is recorded. Management tests goodwill each year for impairment, or when facts or circumstances indicate impairment has occurred. See Note 4 – Fair Value Measurements.

Earnings (Loss) per Share

The Company calculates earnings per share in accordance with Financial Accounting Standards Board (“FASB”) ASC 260, Earnings Per Share, which requires a dual presentation of basic and diluted earnings per share. Basic earnings per share are computed using the weighted average number of shares outstanding during the fiscal year. The Company did1,336,163 shares of common stock underlying convertible promissory notes during the three months ended March 31, 2023 were not have any dilutive common sharesincluded in the computation of diluted Earnings Per Share for the three and nine months ended September 30, 2022.same period as the inclusion would have been antidilutive, given the Company’s net loss.

Equity Based Payments

The Company recognizes compensation costaccounts for equity-based awards based on estimated fair valuepayment accruals under authoritative guidance as set forth in the Topics of the awardASC. The guidance requires all equity-based payments to employees and non-employees, including grants of employee and non-employee stock options and warrants, to be recognized in the consolidated financial statements based at their fair values. The Company applies the provisions of ASC 718, “Compensation - Stock Compensation,” using a modified prospective application, and the Black-Scholes model to value stock options. Under this application, the Company records capitalized cost or compensation expense for all awards granted. Compensation costs will be recognized over the requisiteperiod that an employee provides service period.  in exchange for the award. During the three months ended March 31, 2023 and 2022, the Company granted no securities under its 2020 Stock Incentive Plan and 2022 Stock Option Plan.


11

 

General Concentrations of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk are accounts receivable and other receivables arising from its normal business activities. The Company has a diversified customer base. The Company controls credit risk related to accounts receivable through credit approvals, credit limits, and monitoring procedures. The Company routinely assesses the financial strength of its customers and, based upon factors surrounding the credit risk, establishes an allowance, if required, for un-collectibleuncollectible accounts and, as a consequence, believes that its accounts receivable related credit risk exposure beyond such allowance is limited.

The Company purchases merchandise from six suppliers, and the Company’s three largest suppliers accounted for 95% of total purchases in fiscal 2022. A significant portion of the Company’s inventory is manufactured abroad in Asia. Foreign imports subject the Company to the risks of changes in, or the imposition of new, import tariffs, duties or quotas, new restrictions on imports, loss of “most favored nation” status with the United States for a particular foreign country, antidumping or countervailing duty orders, retaliatory actions in response to illegal trade practices, work stoppages, delays in shipment, freight expense increases, product cost increases due to foreign currency fluctuations or revaluations, public health issues that could lead to temporary closures of facilities or shipping ports, such as the recent outbreak of COVID-19, and other economic uncertainties. If a disruption of trade were to occur from the countries in which the suppliers of the Company’s vendors are located, the Company may be unable to obtain sufficient quantities of products to satisfy its requirements, or the cost of obtaining products may increase.

A substantial amount of the Company’s inventory is manufactured abroad. From time to time, shipping ports experience capacity constraints (such as delays associated with COVID-19), labor strikes, work stoppages or other disruptions that may delay the delivery of imported products. A contract dispute may lead to protracted delays in the movement of the Company’s products, which could further delay the delivery of products to the Company’s online stores and impact net sales and profitability. In addition, other conditions outside of the Company’s control, such as adverse weather conditions or acts of terrorism or war, such as the current conflict in Ukraine, could significantly disrupt operations at shipping ports or otherwise impact transportation of the imported merchandise the Company sells, either through supply chain disruptions or rising freight and fuel costs.

Operating Lease

In accordance with ASC 842, Leases, the Company determines whether an arrangement contains a lease at inception. A lease is a contract that provides the right to control an identified asset for a period of time in exchange for consideration. For identified leases, the Company determines whether it should be classified as an operating or finance lease. Operating leases are recorded in the balance sheet as: right-of-use asset (“ROU asset”) and operating lease liability. ROU asset represents the Company’s right to use an underlying asset for the lease term and lease liability represents the Company’s obligation to make lease payments arising from the lease. ROU assets and operating lease liabilities are recognized at the commencement date of the lease and measured based on the present value of lease payments over the lease term. The ROU asset also includes deferred rent liabilities. The Company’s lease arrangementarrangements generally do not provide an implicit interest rate. As a result, in such situations the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company includes options to extend or terminate the lease when it is reasonably certain that it will exercise that option in the measurement of its ROU asset and liability. Lease expense for the operating lease is recognized on a straight-line basis over the lease term. The Company has a lease agreement with lease and non-lease components, which are accounted for as a single lease component.

Recent Accounting Pronouncements

In December 2019, FASB issued Accounting Standards Update (“ASU”) 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which amends existing guidance related to the accounting for income taxes. This ASU is intended to simplify the accounting for income taxes by removing certain exceptions to the general principles of accounting for income taxes and to improve the consistent application of GAAP for other areas of accounting for income taxes by clarifying and amending existing guidance. This ASU is effective for fiscal years beginning after December 15, 2020, with early adoption permitted. The Company is currently evaluating the effects adoption of this guidance will have on the financial statements and does not expect that the adoption of this ASU will be material to its financial statements.

12

 

Note 3 – Fair Value Measurements

The Company utilizes ASC 820-10, Fair Value Measurement and Disclosure, for valuing financial assets and liabilities measured on a recurring basis. Fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. The guidance also establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the factors market participants would use in valuing the asset or liability. The guidance establishes three levels of inputs that may be used to measure fair value:

Level 1.Observable inputs such as quoted prices in active markets;

Level 2.Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and

Level 3.Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

The Company’scarrying value of financial instruments consisted of cash, operating lease right-of-use assets net, accounts payable and accrued expenses, notes payables, and operating lease liabilities.  The estimatedliabilities recorded at fair value of cash, operating lease right-of-useis measured on a recurring or nonrecurring basis. Financial assets net, and operating lease liabilities approximate its carrying amount duemeasured on a non-recurring basis are those that are adjusted to fair value when a significant event occurs. There were no financial assets or liabilities carried and measured on a nonrecurring basis during the short maturity of these instruments.reporting periods. Financial assets and liabilities measured on a recurring basis are those that are adjusted to fair value each time a financial statement is prepared. There have been no transfers between levels.


13

 

Note 4 – Commitments and Contingencies

Commitments

Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. ROU assets represent ourthe Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Generally, the implicit rate of interest in arrangements is not readily determinable and the Company utilizes its incremental borrowing rate in determining the present value of lease payments. The Company’s incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be. The operating lease ROU asset includes any lease payments made and excludes lease incentives. The Company’s variable lease payments primarily consist of maintenance and other operating expenses from their real estate leases. Variable lease payments are excluded from the ROU assets and lease liabilities and are recognized in the period in which the obligation for those payments is incurred. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term.

The Company has lease agreements with lease and non-lease components. The Company has elected to account for these lease and non-lease components as a single lease component.

In accordance with ASC 842, the components of lease expense were as follows:

Schedule of Lease Cost

For the nine months ended September 30, 2022 
      
 For the three months ended 
 March 31, 
 2023  2022 
Operating lease expense $103,581  $34,527  $34,527 
Total lease expense $103,581  $34,527  $34,527 

In accordance with ASC 842, other information related to leases was as follows:

Schedule of Other information Related to Leases

       
  For the three months ended 
  March 31, 
  2023  2022 
Operating cash flows from operating leases $34,963  $33,945 
Cash paid for amounts included in the measurement of lease liabilities $34,963  $33,945 

 

For the nine months ended September 30, 2022 
Operating cash flows from operating leases $102,174 
Cash paid for amounts included in the measurement of lease liabilities $102,174 
     
Weighted-average remaining lease term—operating leases  0.9 Years 
Weighted-average discount rate—operating leases  3%
Weighted-average remaining lease term—operating leases0.4 Years
Weighted-average discount rate—operating leases3%

In accordance with ASC 842, maturities of operating lease liabilities as of September 30, 2022March 31, 2023 were as follows:

Schedule of Maturities of Operating Lease Liabilities

  Operating 
Year ending: Lease 
2023 (remaining nine months) $58,272 
2024  - 
2025  - 
2026  - 
2027  - 
Total undiscounted cash flows $58,272 
     
Reconciliation of lease liabilities:    
Weighted-average remaining lease terms  0.4 Years 
Weighted-average discount rate  3%
Present values $57,838 
     
Lease liabilities—current  57,838 
Lease liabilities—long-term  - 
Lease liabilities—total $57,838 
     
Difference between undiscounted and discounted cash flows $434 

  Operating 
Year ending: Lease 
2022 (remaining three months) $34,963 
2023  93,236 
2024  - 
2025  - 
2026  - 
Total undiscounted cash flows $128,199 
     
Reconciliation of lease liabilities:    
Weighted-average remaining lease terms   0.9 Years 
Weighted-average discount rate  3%
Present values $126,297 
Lease liabilities—current  126,297 
Lease liabilities—long-term  - 
Lease liabilities—total $126,297 
     
Difference between undiscounted and discounted cash flows $1,902 


14

 

Contingencies

From time to time, the Company may be involved in certain legal actions and claims arising in the normal course of business. Management is of the opinion that such matters will be resolved without material effect on the Company’s financial condition or results of operations.

Note 5 – Debt

Note payable

  September 30,  December 31, 
  2022  2021 
       
March 1, 2021 ($35,000) $35,000  $- 
Total note payable  35,000   - 
Less - current portion  (35,000)  - 
         
Total note payable, less current portion $-  $         - 

The following table provides future minimum payments as of September 30, 2022:

For the years ended Amount 
2022 (remaining three months) $35,000 
2023  - 
2024  - 
2025  - 
2026  - 
Thereafter  - 
     
Total $35,000 

March 1, 2021 – $35,000

On March 1, 2021, an individual loaned Prime Time Live, Inc. $35,000$35,000 in exchange for an unsecured promissory note that included interest at the rate of 10%10% per annum on the unpaid principal balance with all unpaid principal and interest due on or before March 1, 2022. The maturity date was extended to DecemberMay 31, 2022.2023. Interest is due and payable on the first day of each month. At September 30,As of March 31, 2023 and December 31, 2022, Prime Time Live, Inc. owes $35,000 in principalthe balance was $35,000 and accrued interest of $875 and $1,167 for the three and nine months ended September 30, 2022.$35,000, respectively.

Convertible note payables

Schedule of Convertible Note Payables

  September  30,  December  31, 
  2022  2021 
       
August 3, 2022 ($1,000,000) $1,000,000  $           - 
September 29, 2022 ($50,000)  50,000   - 
September 29, 2022 ($500,000)  500,000   - 
Total convertible note payables  1,550,000   - 
Less - current portion  -   - 
         
Total convertible note payables, less current portion $1,550,000  $- 


       
  March 31,  December 31, 
  2023  2022 
       
August 3, 2022 ($5,000,000) $5,000,000  $5,000,000 
August 3, 2022 ($1,000,000)  1,000,000   1,000,000 
August 22, 2022 ($500,000)  500,000   500,000 
September 22, 2022 ($250,000)  250,000   250,000 
September 25, 2022 ($600,000)  600,000   600,000 
September 25, 2022 ($600,000)  600,000   600,000 
September 29, 2022 ($50,000)  50,000   50,000 
September 29, 2022 ($500,000)  500,000   500,000 
October 10, 2022 ($500,000)  500,000   500,000 
October 13, 2022 ($750,000)  75,000   75,000 
October 13, 2022 ($50,000)  50,000   50,000 
October 14, 2022 ($50,000)  50,000   50,000 
January 4, 2023 ($500,000)  500,000   - 
         
Total convertible note payables (current) $9,675,000  $9,175,000 

The following table provides future minimum payments as of September 30, 2022:

For the years ended Amount 
2022 (remaining three months) $- 
2023  1,550,000 
2024  - 
2025  - 
2026  - 
Thereafter  - 
     
Total $1,550,000 

TheFrom August 3, 2022 through November 28, 2022, the Company conducted a convertible note offering for a maximum offering of $15,000,000$15,000,000 and a minimum of $2,000,000$2,000,000 (the “Convertible Note Offering”).

15

 

Pursuant to the terms of the Convertible Note, the principal amount of the Note that may be outstanding from time to time shall bearbears interest per annum until paid in full at a rate equal to 6%6%, compounded annually. The principal and interest of the Note shall beis due and payable to the noteholder on the one-year anniversary of the date of the Note (the “Maturity Date”) unless all principal and interest due under the Note hadhas been converted by the Maturity Date.

The conversion price shall beis equal to $0.25$0.25 per share of Common Stock. Any time prior to the Maturity Date, and upon the date of effectiveness of registration of the Notes on a registration statement filed with the Securities and Exchange Commission (the “SEC”), the Note shall automatically convert to shares of common stock of the Company at the Conversion Price (the “Automatic Conversion”); provided however, that in the event that Conversion Shares represent greater than 4.99% of the total Common Shares of the Company (the portion above 4.99% referred to herein as the “Excess Shares”), then the Automatic Conversion shall only apply to such portion of the Note up to 4.99% and not include the Excess Shares. This Note isThe Notes are convertible at the option of the Noteholder, in holder’s sole discretion, in whole or in part, at any time prior to the Maturity Date or payment in full of the Note, whichever occurs first, all or any portion of principal or interest, into shares of Common Stock of the Company at the Conversion Price.

The Company analyzed the conversion option in the Notes for derivative accounting treatment under ASC Topic 815, “Derivatives and Hedging,” and determined that the instruments do not qualify for derivative accounting.

As of September 30,December 31, 2022, the Company has received $1,550,000$9,175,000 from three12 accredited investors pursuant to the Convertible Note Offering.

As of March 31, 2023, the Company has received $9,675,000 from 13 accredited investors pursuant to the Convertible Note Offering.

Note 6 – Stockholders’ EquityDeficit

Preferred Stock

Class A Convertible Stock

As of March 31, 2023, the Company has authorized 30,000,000 shares of preferred stock. At September 30, 2022March 31, 2023 and December 31, 2021,2022, there are a total of 500,000 shares of Class A Convertible shares of preferred stock (“Class A”) issued and outstanding. The Class A shares provide that when voting as a single class, the shares shall have the votes and the voting power at all times of at least 60% of the voting power of the Company. Further, the holders of the Class A shares at their discretion and subject to a change of control or listing of the common stock of the Company on either the NASDAQ or NYSE stock exchanges,, can convert their one share of Class A into two shares of the Company’s common stock, subject to adjustment. In addition, the holder of the shares of Class A is entitled to a liquidation preference of the Company senior to all other securities of the Company.


Common Stock

The Company’s common stock at September 30, 2022 consistsAs of 200,000,000March 31, 2023, the Company has 300,000,000 authorized shares of $0.0001common stock par value common stock.$0.0001 per share. At September 30, 2022March 31, 2023 and December 31, 2021,2022, there was a total of 117,893,4603,929,834 shares of common stockand 3,929,834 shares issued and outstanding, and 10,803,504 shares of common stock issued and outstanding, respectively.

16

 

Common Stock and Recapitalization

As a result of reverse merger and LimitlessX being the acquirer, the Company retrospectively restated its common stock as if the transaction occurred beginning of the period. The following is the reconciliation of retrospectively restated common stock:

  December 31, 2021 
  Issued  Issuable  Total 
          
Common stock – Limitless X Inc. – as original  48,500,000   1,500,000   50,000,000 
Common stock split (1 to 1.94) – Limitless X Inc.  45,590,000   1,410,000   47,000,000 
Common stock issuable (additional stock split) – Limitless X Inc.  -   9,000,000   9,000,000 
Common stock (Bio Lab) – prior to reverse merger  10,803,504   -   10,803,504 
             
Total as of December 31, 2021 – as retrospectively restated  104,893,504   11,910,000   116,803,504 

Note 7 – Equity Based Payments

The Company accounts for equity-based payment accruals under authoritative guidance as set forth in the Topics of the ASC. The guidance requires all equity-based payments to employees and non-employees, including grants of employee and non-employee stock options and warrants, to be recognized in the consolidated financial statements based at their fair values.

Stock Incentive Plans

Effective January 15, 2020, the Company adopted its 2020 Stock Option and Award Plan (the “2020 Stock Incentive Plan”). Under the 2020 Stock Incentive Plan, the Board of Directors may grant options or purchase rights to purchase common stock to officers, employees, and other persons who provide services to the Company or any related company. The participants to whom awards are granted, the type of awards granted, the number of shares covered for each award, and the purchase price, conditions and other terms of each award are determined by the Board of Directors, except that the term of the options shall not exceed ten years. A total of 2,000,0002,222 shares of the Company’s common stock is reserved for the 2020 Stock Incentive Plan. The shares issued for the 2020 Stock Incentive Plan may be either treasury or authorized and unissued shares. During the ninethree months ended September 30,March 31, 2023 and 2022, and 2021, the Company granted no options under the 2020 Stock Incentive Plan. As of March 31, 2023, there have been no shares of common stock granted under the under the 2020 Stock Incentive Plan.

Effective August 9, 2022, the Company adopted its 2022 Incentive and Nonstatutory Stock Option Plan (the “2022 Stock Option Plan”). Under the 2022 Stock Option Plan, the Board of Directors may grant options to purchase common stock to officers, employees, and other persons who provide services to the Company. A total of 25,000,000833,333 shares of the Company’s common stock is reserved for the 2022 Stock Option Plan. During the nine months ended September 30, 2022, the CompanyAs of March 31, 2023, there have been no options to purchase shares of common stock granted no options under the 2022 Stock Option Plan.

Effective August 9, 2022, the Company adopted its 2022 Restricted Stock Plan (the “2022 Restricted Stock Plan”). Under the 2022 Restricted Stock Plan, the Board of Directors may grant restricted stock to officers, directors, and key employees. A total of 25,000,000833,333 shares of the Company’s common stock is reserved for the 2022 Restricted Stock Option Plan. During the nine months ended September 30, 2022, the Company granted As of March 31, 2023, there have been no shares of common stock granted under the 2022 Restricted Stock Plan.


17

 

Note 8 – Related Party Transactions

Consulting Fees

During the three and nine months ended September 30,March 31, 2023 and 2022, the Company incurred consulting fees in the amount of $0$7,000 and $32,500$0, respectively, to an officer and an officer of one of its affiliates.

Royalty Payables

Limitless Performance Inc. (“LPI”), SMILZ INC. (“Smiles”), DIVATRIM INC. (“Divatrim”), and AMAROSE INC. (“Amarose”) are all companies at least 50% owned by a shareholder of the Company.

On December 1, 2021, the Company entered into a manufacturing and distributorship license agreement with LPI for the Company to distribute LPI products and for payments to LPI for its product designs and distribution rights. The Company shall pay to LPI from time to time royalty payments equal to 4.00%4.00% of gross sales, excluding returns, chargebacks, and other such allowances.

On December 1, 2021, the Company entered into a manufacturing and distributorship license agreement with Smiles for the Company to distribute Smiles products and for payments to Smiles for its product designs and distribution rights. The Company shall pay to Smiles from time to time royalty payments equal to 4.00%4.00% of gross sales, excluding returns, chargebacks, and other such allowances.

On December 1, 2021, the Company entered into a manufacturing and distributorship license agreement with Divatrim for the Company to distribute Divatrim products and for payments to Smiles for its product designs and distribution rights. The Company shall pay to Divatrim from time to time royalty payments equal to 4.00%4.00% of gross sales, excluding returns, chargebacks, and other such allowances.

On December 1, 2021, the Company entered into a manufacturing and distributorship license agreement with Amarose for the Company to distribute Amarose products and for payments to Smiles for its product designs and distribution rights. The Company shall pay to Amarose from time to time royalty payments equal to 4.00%4.00% of gross sales, excluding returns, chargebacks, and other such allowances.

Effective April 1, 2022, theThe Company shall paywas required to start paying all earned royalties to LPI, Smiles, Divatrim, and Amarose beginning on June 15, 2022. As of September 30,March 31, 2023 and December 31, 2022, the royalty payable is in the amount of $704,203.$1,399,031 and 1,114,403, respectively.

18

 

Note payables to shareholder

  September  30,  December  31, 
  2022  2021 
       
December 6, 2021 ($50,000) $50,000  $50,000 
February 11, 2022 ($150,000)  150,000   - 
May 8, 2022 ($550,000)  550,000   - 
May 9, 2022 ($1,100,000)  1,100,000   - 
May 16, 2022 ($450,000)  450,000   - 
June 1, 2022 ($500,000)  500,000   - 
June 30, 2022 ($922,028)  922,028   - 
Total loan payables to shareholder  3,722,028   50,000 
Less - current portion  (3,722,028)  (28,802)
         
Total loan payables to shareholder, less current portion $-  $21,198 


The following table provides future minimum payments asSchedule of September 30, 2022:Note Payables to Related Party Transaction

       
  March 31,  December 31, 
  2023  2022 
       
December 6, 2021 ($50,000) $50,000  $50,000 
February 11, 2022 ($150,000)  150,000   150,000 
May 8, 2022 ($550,000)  550,000   550,000 
May 16, 2022 ($1,100,000)  1,100,000   1,100,000 
May 18, 2022 ($450,000)  450,000   450,000 
June 1, 2022 ($500,000)  500,000   500,000 
June 30, 2022 ($922,028)  922,028   922,028 
August 25, 2022 ($290,000)  290,000   290,000 
November 15, 2022 ($450,000)  450,000   450,000 
         
Total loan payables to shareholder (current) $4,462,028  $4,462,028 

For the years ended Amount 
2022 (remaining three months) $2,484,747 
2023  1,237,281 
2024  - 
2025  - 
2026  - 
Thereafter  - 
     
Total $3,722,028 

December 6, 2021 – $50,000

On December 6, 2021, Limitless X Inc. (“Limitless X”)the Company executed the standard loan documents required for securing a loan of $50,000 $50,000 from a shareholder. As of September 30, 2022March 31, 2023 and December 31, 2021,2022, the balance is $50,000 was $50,000 and $50,000,$50,000, respectively.

Pursuant to that certain Loan Authorization and Agreement, Limitless Xthe Company borrowed an aggregate principal amount of $50,000,$50,000, with proceeds to be used for working capital purposes. Beginning on June 1, 2022, the loan requires a payment of $4,303 $4,303 per month which includes principal and interest with an interest rate of 6%6%. The total balance of principal and interest of $51,640 $51,640 is due on May 1, 2023.2023.

February 11, 2022 – $150,000

On February 11, 2022, Limitless Xthe Company executed standard loan documents required for securing a loan of $150,000 $150,000 from a shareholder. As of September 30,March 31, 2023 and December 31, 2022, the balance is $150,000.

was $150,000 and $150,000, respectively. Pursuant to that certain Loan Authorization and Agreement, Limitless Xthe Company borrowed an aggregate principal amount of $150,000,$150,000, with proceeds to be used for working capital purposes. Beginning on June 1, 2022, the loan requires a payment of $12,910 $12,910 per month which includes principal and interest with an interest rate of 6%6%. The total balance of principal and interest of $154,920 $154,920 is due on May 1, 2023.2023.

May 8, 2022 – $550,000

On May 8, 2022, Limitless Xthe Company executed standard loan documents required for securing a loan of $550,000 $550,000 from a shareholder. As of September 30,March 31, 2023 and December 31, 2022, the balance is $550,000.

was $550,000 and $550,000, respectively. Pursuant to that certain Loan Authorization and Agreement, Limitless Xthe Company borrowed an aggregate principal amount of $550,000,$550,000, with proceeds to be used for working capital purposes. Beginning on June 1, 2022, the loan requires a payment of $47,337 $47,337 per month which includes principal and interest with an interest rate of 6%6%. The total balance of principal and interest of $568,038 $568,038 is due on May 1, 2023.2023.


19

 

 

May 16, 2022 – $1,100,000

On May 16, 2022, Limitless Xthe Company executed standard loan documents required for securing a loan of $1,100,000 $1,100,000 from a shareholder. As of September 30,March 31, 2023 and December 31, 2022, the balance iswas $1,100,001,100,000 .

and $1,100,000, respectively. Pursuant to that certain Loan Authorization and Agreement, Limitless Xthe Company borrowed an aggregate principal amount of $1,100,000,$1,100,000, with proceeds to be used for working capital purposes. Interest began accruing at the rate of 8.5%8.5% on June 17, 2022.2022.

May 18, 2022 – $450,000

On May 8,18, 2022, Limitless Xthe Company executed standard loan documents required for securing a loan of $450,000 $450,000 from a shareholder. As of September 30,March 31, 2023 and December 31, 2022, the balance is $550,000.

was $450,000 and $450,000, respectively. Pursuant to that certain Loan Authorization and Agreement, Limitless Xthe Company borrowed an aggregate principal amount of $450,000,$450,000, with proceeds to be used for working capital purposes. Interest began accruing at the rate of 8.5%8.5% on June 19, 2022.2022.

June 1, 2022 – $500,000

On June 1, 2022, Limitless Xthe Company executed standard loan documents required for securing a loan of $500,000 $500,000 from a shareholder. As of September 30,March 31, 2023 and December 31, 2022, the balance is $500,000.

was $500,000 and $500,000, respectively. Pursuant to that certain Loan Authorization and Agreement, Limitless Xthe Company borrowed an aggregate principal amount of $500,000,$500,000, with proceeds to be used for working capital purposes. Beginning on August 1, 2022, the loan requires a payment of $43,494 $43,494 per month which includes principal and interest with an interest rate of 8%8%. The total balance of principal and interest of $521,931 $521,931 is due on July 1, 2023.2023.

June 30, 2022 – $922,028

On June 30, 2022, Limitless Xthe Company executed standard loan documents required for securing a loan of $922,028 $922,028 from a shareholder. As of September 30,March 31, 2023 and December 31, 2022, the balance is $922,028.

was $922,028 and $922,028, respectively. Pursuant to that certain Loan Authorization and Agreement, Limitless Xthe Company borrowed an aggregate principal amount of $922,028,$922,028, with proceeds to be used for working capital purposes. Beginning on August 1, 2022, the loan requires a payment of $80,206 $80,206 per month which includes principal and interest with an interest rate of 8%8%. The total balance of principal and interest of $962,469 $962,469 is due on August 1, 2023.2023.

Note payables to related parties

  September  30,  December 31, 
  2022  2021 
       
April 1, 2022 ($237,610) $237,610  $       - 
May 10, 2022 ($12,500)  12,500   - 
May 10, 2022 ($12,500)  12,500   - 
May 10, 2022 ($20,000)  20,000   - 
May 31, 2022 ($5,000)  5,000   - 
May 31, 2022 ($15,000)  15,000   - 
June 9, 2022 ($15,000)  15,000   - 
Total note payables to related parties  317,610   - 
Less - current portion  (317,610)  - 
         
Total note payables to related parties, less current portion $-  $- 


The following table provides future minimum payments as of September 30, 2022:

For the years ended Amount 
2022 (remaining three months) $276,681 
2023  40,929 
2024  - 
2025  - 
2026  - 
Thereafter  - 
     
Total $317,610 

April 1,August 25, 2022 – $237,610$290,000

On April 1,August 25, 2022, Limitless Xthe Company executed standard loan documents required for securing a loan of $290,000 from a shareholder due on demand. As of March 31, 2023 and December 31, 2022, the balance was $290,000 and $290,000, respectively. Pursuant to that certain Loan Authorization and Agreement, the Company borrowed an aggregate principal amount of $290,000 to be used for working capital purposes and with an interest rate of 10%.

November 15, 2022 – $450,000

On November 15, 2022, the Company executed loan documents for securing a loan of $450,000 from a shareholder due on demand. As of March 31, 2023 and December 31, 2022, the balance was $450,000 and $450,000, respectively. Pursuant to that certain Loan Authorization and Agreement, the Company borrowed an aggregate principal amount of $450,000 to be used for working capital purposes and with an interest rate of 10%.

20

Note payables to related parties

Schedule of Note Payables to Related Party Transaction

       
  March 31,  December 31, 
  2023  2022 
       
April 1, 2022 ($237,610) $237,610  $237,610 
May 10, 2022 ($12,500)  12,500   12,500 
May 10, 2022 ($12,500)  12,500   12,500 
May 10, 2022 ($20,000)  20,000   20,000 
May 31, 2022 ($5,000)  5,000   5,000 
May 31, 2022 ($15,000)  15,000   15,000 
June 9, 2022 ($15,000)  15,000   15,000 
December 31, 2022 ($929,401)  929,401   929,401 
         
Total note payables to related parties (current) $1,247,011  $1,247,011 

April 1, 2022 – $237,610

On April 1, 2022, Limitless X executed loan documents for securing a loan of $237,610 from Emblaze One, a company owned by a shareholder. As of September 30,March 31, 2023 and December 31, 2022, the balance is $237,610.was $237,610 and $237,610, respectively.

Pursuant to that certain Loan Authorization and Agreement, Limitless X borrowed an aggregate principal amount of $237,610,$237,610, with proceeds to be used for working capital purposes. Beginning on September 1, 2022, the loan requires a payment of $20,669$20,669 per month which includes principal and interest with an interest rate of 8%8%. The total balance of principal and interest of $248,032$248,032 is due on August 1, 2023.2023.

May 10, 2022 ($12,500)- $12,500

On May 10, 2022, a related party of the Company loaned Prime Time Live, Inc. $12,500$12,500 in exchange for a promissory note that includedincludes interest at the rate of 10%10% per annum on the unpaid principal balance with all unpaid principal and interest due on or before May 10, 2023.2023. Interest began accruing at the rate of 10%10% on May 10, 2022. As of March 31, 2023 and December 31, 2022, the balance was $12,500 and $12,500, respectively.

May 10, 2022 ($12,500)- $12,500

On May 10, 2022, a related party of the Company loaned Prime Time Live, Inc. $12,500$12,500 in exchange for a promissory note that includedincludes interest at the rate of 10%10% per annum on the unpaid principal balance with all unpaid principal and interest due on or before May 10, 2023.2023. Interest began accruing at the rate of 10%10% on May 10, 2022. As of March 31, 2023 and December 31, 2022, the balance was $12,500 and $12,500, respectively.

May 10, 2022 ($20,000)- $20,000

On May 10, 2022, a related party of the Company loaned Prime Time Live, Inc. $20,000$20,000 in exchange for a promissory note that included interest at the rate of 10%10% per annum on the unpaid principal balance with all unpaid principal and interest due on or before May 10, 2023.2023. Interest began accruing at the rate of 10%10% on May 10, 2022. As of March 31, 2023 and December 31, 2022, the balance was $20,000 and $20,000, respectively.

May 31, 2022 ($5,000)- $5,000

On May 31, 2022, a related party of the Company loaned Prime Time Live, Inc. $5,000$5,000 in exchange for a promissory note that included interest at the rate of 10%10% per annum on the unpaid principal balance with all unpaid principal and interest due on or before May 31, 2023.2023. Interest began accruing at the rate of 10%10% on May 31, 2022. As of March 31, 2023 and December 31, 2022, the balance was $5,000 and $5,000, respectively.

21

May 31, 2022 ($15,000)- $15,000

On May 31, 2022, a related party of the Company loaned Prime Time Live, Inc. $15,000$15,000 in exchange for a promissory note that included interest at the rate of 10%10% per annum on the unpaid principal balance with all unpaid principal and interest due on or before May 31, 2023.2023. Interest will began accruing at the rate of 10%10% on May 31, 2022. As of March 31, 2023 and December 31, 2022, the balance was $15,000 and $15,000, respectively.

June 9, 2022 ($15,000)- $15,000

On May 10, 2022, a related party of the Company loaned Prime Time Live, Inc. $15,000$15,000 in exchange for a promissory note that included interest at the rate of 10%10% per annum on the unpaid principal balance with all unpaid principal and interest due on or before May 10, 2023.2023. Interest began accruing at the rate of 10%10% on May 10, 2022. As of March 31, 2023 and December 31, 2022, the balance was $15,000 and $15,000, respectively.

December 31, 2022 - $929,401

On December 31, 2022, the Company executed loan documents for securing a loan of $929,401 from Emblaze One, a company owned by a shareholder. As of March 31, 2023 and December 31, 2022, the balance was $929,401 and $929,401, respectively.

Pursuant to that certain Loan Authorization and Agreement, the Company borrowed an aggregate principal amount of $929,401 with an interest rate of 8% to be used for working capital purposes due on December 1, 2023.

Note 9 – Subsequent Events

The Company evaluated all events or transactions that occurred after September 30, 2022.March 31, 2023. During this period, the Company did not have any material recognizable subsequent events required to be disclosed other than the following:

On May 4, 2023, the Company terminated the 2020 Stock Incentive Plan.

Convertible note payables

Subsequent to September 30, 2022, the Company received $4,700,000 from five accredited investors as part of the Convertible Note Offering.


22

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

Forward-Looking Statements and Associated Risks.

This Form 10-Q contains certain statements that are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained in this Form 10-Q that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, words such as “may,” “expect,” “believe,” “anticipate,” “estimate,” “continue” or comparable terminology are intended to identify forward-looking statements. These statements by their nature involve substantial risks and uncertainties, and actual results may differ materially depending on a variety of factors, many of which are not within our control. These factors include but are not limited to economic conditions generally and in the industries in which we may participate; competition within our chosen industry, including competition from much larger competitors; and failure to successfully develop business relationships.

INTRODUCTION

As previously reported on a Current Report on Form 8-K filed with the Securities and Exchange CommissionSEC on May 13, 2022, the registrant, Bio Lab Naturals, Inc., a Delaware corporation (“Bio Lab”), entered into a Share Exchange Agreement (the “Agreement”“Share Exchange Agreement”) with Limitless X, Inc., a Nevada corporation (“LimitlessX”), and its 11 shareholders (the “LimitlessX Acquisition”) on May 11, 2022 (the “Merger”).2022. The parties completed and closed the LimitlessX Acquisition on May 20, 2022 by issuing an aggregate of 97,000,0003,233,334 shares of common stock of Bio Lab to the LimitlessX shareholders (the “Closing”“Acquisition Closing”). According to the terms of the Share Exchange Agreement, Bio Lab is obligated to issuethen issued an additional 9,000,000300,000 shares of common stock to the LimitlessX shareholders pro rata to their interests in approximately six months from the Acquisition Closing as part of the Limitless Acquisition. Concurrently with the LimitlessX Acquisition, Jaspreet Mathur, the founder and principal shareholder of LimitlessX, also purchased from Helion Holdings LLC, 500,000 shares of Bio Lab’s Class A Preferred Convertible Stock, which at all times have a number of votes equal to 60% of all of the issued and outstanding shares of common stock of Bio Lab.

For accounting purposes, the LimitlessX Acquisition was accounted for as a “reverse merger” with LimitlessX as the accounting acquiror (legal acquiree) and Bio Lab as the accounting acquiree (legal acquiror). and, consequently, the transaction was treated as a recapitalization of Bio Lab. Since LimitlessX was deemed to be the accounting acquiror in the LimitlessX Acquisition, the historical financial information for periods prior to the LimitlessX Acquisition reflect the financial information and activities solely of LimitlessX and not of Bio Lab. No step-up in basis or intangible assets or goodwill was recorded in this transaction.

On June 10, 2022, Bio Lab changed its name to Limitless X Holdings Inc. (“we,” “us,” or “our”).

23

 

The Merger was accounted for as a “reverse merger” following the completion of the transaction. For accounting purposes, LimitlessX was deemed to be the accounting acquirer in the transaction and, consequently, the transaction was treated as a recapitalization of Bio Lab. Accordingly, LimitlessX’s assets, liabilities, and results of operations became the historical financial statements of the registrant.

RESULTS OF OPERATION

For the Three Months Ended September 30, 2022March 31, 2023 Compared to the Three Months Ended June 30,March 31, 2022

  For the three months ended  For the three months ended       
  March 31, 2023  March 31, 2022  Changes 
  Amount  % of Sales  Amount  % of Sales  Amount  % 
Revenue                        
Product sales $6,563,037   96% $7,075,362   100% $(512,325)  (7%)
Service revenue  291,764   4%  -   0%  291,764   N/A 
Rentals  15,000   0%  -   0%  15,000   N/A 
Total revenue  6,869,801   100%  7,075,362   100%  (205,561)  (3%)
                         
Cost of sales                        
Cost of sales  1,229,894   18%  882,549   12%  347,345   39%
Total cost of sales  1,229,894   18%  882,549   12%  347,345   39%
                         
Gross profit  5,639,907   82%  6,192,813   88%  (552,906)  (9%)
                         
Operating expenses:                        
General and administrative  586,206   9%  31,534   0%  554,672   1,759%
Advertising and marketing  10,055,504   146%  5,243,678   74%  4,811,826   92%
Transaction fees  411,268   6%  14,481   0%  396,787   2,740%
Merchant fees  713,194   10%  354,683   5%  358,511   101%
Royalty fees  284,628   4%  -   0%  284,628   N/A 
Professional fees  539,157   8%  44,500   1%  494,657   1,112%
Payroll and payroll taxes  1,335,927   19%  70,422   1%  1,265,505   1,797%
Rent  41,059   1%  43,257   1%  (2,198)  (5%)
Dad debt expense  232,374   3%  -   0%  232,374   N/A 
Consulting fees, related party  7,000   0%  -   0%  7,000   N/A 
Total operating expenses  14,206,317   207%  5,802,555   82%  8,403,762   145%
                         
Income (loss) from operations  (8,566,410)  (125%)  390,258   6%  (8,956,668)  (2,295%)
                         
Other income (expense)                        
Interest expense  (225,627)  (3%)  -   0%  (225,627)  N/A 
Total other income (expense), net  (225,627)  (3%)  -   0%  (225,627)  N/A 
                         
Income (loss) before income taxes  (8,792,037)  (128%)  390,258   6%  (9,182,295)  (2,353%)
                         
Income tax provision  48   0%  81,954   1%  (81,906)  (100%)
                         
Net income (loss) $(8,792,085)  (128%) $308,304   4% $(9,100,389)  (2,952%)

 

24

We were incorporated in the State of Nevada on September 27, 2021. Consequently, we did not have any activity for the six and three months ended September 30, 2021.

 

Product Sales -Our netproduct sales increaseddecreased by 92.6%7% to $21.5$6.6 million for the three months ended September 30, 2022March 31, 2023 as compared to $11.2$7.1 million for the three months ended June 30,March 31, 2022. Sales increaseIn 2023, there was due to a shift in our marketing strategies, including strategic advertisement placementsa change in performance marketers.

Service Revenue - Our service revenue increased by $291,764 to $291,764 for the three months ended March 31, 2023 as compared to $0 for the three months ended March 31, 2022. Our service revenue increase was primarily due to us starting our marketing services in May 2022.

Cost of Sales - Our cost of sales increased from $882,549, 12% of sales, to $1.2 million, 18% of sales. This increase was primarily due to our new product lines that began being sold in November 2022 with celebritieslower margins. As operations increased during the period, so did our costs for freight, inventory, and more effective product placement.other supplies.

Gross Profit - Gross profit for the three months ended September 30, 2022March 31, 2023 was $18.4$5.6 million compared to $9.2$6.2 million for the three months ended June 30,March 31, 2022. The increasedecrease in gross profit of $9.2 million$347,345 was due toprimarily a shift in our marketing strategies, including strategic advertisement placements with celebrities and more effective product placement.a change in performance marketers.

Operating Expenses - During the three months ended September 30, 2022,March 31, 2023, we recognized $21.2$14.2 million in operating expenses compared to $15.4$5.8 million for the three months ended June 30,March 31, 2022. The increase of $5.8$8.4 million in operating expenses was primarily fromdue to advertising and marketing, payroll, transaction fees, merchant fees, royalty fees, and merchant fees.bad debt expense.

Our advertising and marketing expense increased by $4.8 million due to a shift in marketing strategies to heavily push our related products by using performance marketers and celebrity endorsements.
The increase in transaction payroll is related to accruals of unpaid salaries.
The increase in transaction fees and merchant fees are directly related to the increased number of transactions during the three months ended March 31, 2023.
The increase of $232,374 in bad debt expense was due to accounts receivable being deemed uncollectible.
Beginning on April 1, 2022, we began accruing royalties per the manufacturing and distributorship license agreements of 4.00% of gross sales, excluding returns, chargebacks, and other such allowances. Thus, the royalty fees increased by $284,628 during the March 31, 2023.

LIQUIDITY AND CAPITAL RESOURCES

Operating Activities

During the ninethree months ended September 30, 2022,March 31, 2023, net cash used in operating activities was $6,761,913.$6.2 million. The cash used in operating activities was primary due to net loss and timing of settlement of assets and liabilities including stock compensation expenses.liabilities.


 

Investing Activities

Net cash provided byused in investing activities for the ninethree months ended September 30, 2022March 31, 2023 was $28,397. During the nine months ended September 30, 2022, $28,397 was provided by proceeds from the disposition of an asset.$1,604.

Financing Activities

Net cash provided by financing activities for the ninethree months ended September 30, 2022March 31, 2023 was $7,574,638.$500,000. This amount was incurred by increased borrowings from related parties, shareholders, and investors and proceeds from issuance of common stock.investors.

25

 

Off Balance Sheet Arrangements

None.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

ITEM 4. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer evaluated the effectiveness of our disclosure controls and procedures pursuant to Rules 13a-15(e) and 15d-15(e) under the Exchange Act. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.

Based on management’s evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as a result of the material weakness described below, as of September 30, 2022,March 31, 2023, our disclosure controls and procedures were not designed at a reasonable assurance level and are ineffective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

The material weakness, which relates to internal control over financial reporting, that was identified is:

We did not have sufficient personnel in our accounting and financial reporting functions. As a result, we were not able to achieve adequate segregation of duties and were not able to provide for independent adequate reviewing of the financial statements. This control deficiency, which is pervasive in nature, results in a reasonable possibility that material misstatements of the financial statements will not be prevented or detected on a timely basis.

Management believes that the hiring of additional personnel who have the technical expertise and knowledge with the non-routine or technical issues we have encountered in the past will result in both proper recording of these transactions and a much more knowledgeable finance department as a whole. Due to the fact that our accounting staff consists of a Chief Financial Officer, a bookkeeper, and external accounting consultants, additional personnel will also ensure the proper segregation of duties and provide more checks and balances within the department. Additional personnel will also provide the cross training needed to support us if personnel turnover issues within the department occur. We believe this will eliminate or greatly decrease any control and procedure issues we may encounter in the future.

We will continue to monitor and evaluate the effectiveness of our disclosure controls and procedures and our internal controls over financial reporting on an ongoing basis and are committed to taking further action and implementing additional enhancements or improvements, as necessary and as funds allow.

Changes in Internal Control Over Financial Reporting

We recently hired a new Chief Financial Officer and have new management. We anticipate that our management, including our Chief Financial Officer, and our independent registered public accounting firm, will discuss the status of our financial controls and procedures and determine what changes are necessary to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of our financial statements for external purposes in accordance with U.S. GAAP. We anticipate that a number of changes in our financial controls and procedures will be made in the ensuing periods.


26

 

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

None.

ITEM 1A. RISK FACTORS

Our CurrentAnnual Report on Form 8-K,10-K, filed with the SEC, on May 26, 2022,April 17, 2023, describes important risk factors that could cause our business, financial condition, results of operations, and growth prospects to differ materially from those indicated or suggested by forward-looking statements made in this Quarterly Report on Form 10-Q or presented elsewhere by management from time to time. There have been no material changes in the risk factors that appear in our CurrentAnnual Report on Form 8-K.10-K. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may also materially and adversely affect our business.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURE

Not Applicable.

ITEM 5. OTHER INFORMATION

Not Applicable.

ITEM 6. EXHIBITS

Exhibits. The following is a complete list of exhibits filed as part of this Form 10-Q. Exhibit numbers correspond to the numbers in the Exhibit Table of Item 601 of Regulation S-K.

31.1Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934
31.2Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934
32.1Certification of Chief Executive Officer under Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2Certification of Chief Financial Officer under Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INSXBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCHXBRL Taxonomy Extension Schema Document
101.CALXBRL Taxonomy Extension Calculation Linkbase Document
101.DEFXBRL Taxonomy Extension Definition Linkbase Document
101.LABXBRL Taxonomy Extension Label Linkbase Document
101.PREXBRL Taxonomy Extension Presentation Linkbase Document
104Cover Page Interactive Data File (formatted as an Inline XBRL document and included in Exhibit 101)


27

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

LIMITLESS X HOLDINGS INC.
(Registrant)
Dated: November 10, 2022May 15, 2023By:/s/ Jaspreet Mathur
Jaspreet Mathur
(Chief Executive Officer,
Principal Executive Officer)
Dated: November 10, 2022May 15, 2023By:/s/ Benjamin Chung
Benjamin Chung

(Chief Financial Officer,

Principal Financial and Accounting Officer) Officer)

28

21

NONE 0.02 0.14 113686938 59582185 110000 false --12-31 Q3 0001803977 iso4217:USD xbrli:shares